Loading clinical trials...
Loading clinical trials...
Phase IB With Expansion of Patients at the MTD Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Conditions
Interventions
AUY922
Cetuximab
Locations
1
United States
Swedish Medical Center Cancer Institute
Seattle, Washington, United States
Start Date
February 1, 2011
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
June 8, 2015
NCT04704661
NCT07297004
NCT04389086
NCT04616183
NCT05038254
NCT05877352
Lead Sponsor
Swedish Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions